Sagimet Biosciences
SGMT
SGMT
48 hedge funds and large institutions have $130M invested in Sagimet Biosciences in 2023 Q3 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+48
Holders Change %
–
% of All Funds
0.77%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
48
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
NMC
NEA Management Company
Timonium,
Maryland
|
$27.1M |
2 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
$23.5M |
3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
$12.8M |
4 |
AG
Artal Group
Luxembourg
|
$8.14M |
5 |
BBA
Baker Bros. Advisors
New York
|
$7.18M |
Top Sellers
No sellers this quarter